Early laboratory diagnosis of COVID-19 by antigen detection in blood samples of the SARS-COV-2 nucleocapsid protein

Rebekka F Thudium, Malene P Stoico, Estrid Høgdall, Julie Høgh, Henrik B Krarup, Margit A H Larsen, Poul H Madsen, Susanne D Nielsen, Sisse R Ostrowski, Amanda Palombini, Daniel B Rasmussen, Niels T Foged*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

27 Citations (Scopus)
37 Downloads (Pure)

Abstract

The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection and from 505 outpatients predominantly with relevant symptoms of COVID-19 simultaneously with PCR testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confirmed infection, the diagnostic sensitivity of the ELISA was 91.6%. The mean NP concentration of the 131 ELISA-positive blood samples was 1,734 pg/ml (range, 10 to 3,840 pg/ml). An exponential decline in NP concentration was observed for 368 blood samples collected over the first 4 weeks after PCR-confirmed SARS-CoV-2 infection, and all blood samples taken later had an NP concentration below the 10-pg/ml diagnostic cutoff. The diagnostic sensitivity of the ELISA was 81.4% for the 43 blood samples collected from outpatients with a simultaneous positive PCR test, and the mean NP concentration of the 35 ELISA-positive samples was 157 pg/ml (range, 10 to 1,377 pg/ml). For the 462 outpatients with a simultaneous negative PCR test, the diagnostic specificity of the ELISA was 99.8%. In conclusion, the SARS-CoV-2 NP ELISA is a suitable laboratory diagnostic test for COVID-19, particularly for hospitals, where blood samples are readily available and screening of serum or plasma by ELISA can facilitate prevention of nosocomial infections and reduce the requirement for laborious swab sampling and subsequent PCR analysis to confirmatory tests only.

Original languageEnglish
Article numbere01001-21
JournalJournal of Clinical Microbiology
Volume59
Issue number10
Number of pages35
ISSN0095-1137
DOIs
Publication statusPublished - 20 Sept 2021

Keywords

  • Antibodies, Viral
  • COVID-19
  • Clinical Laboratory Techniques
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Laboratories
  • Nucleocapsid Proteins/genetics
  • SARS-CoV-2
  • Sensitivity and Specificity

Fingerprint

Dive into the research topics of 'Early laboratory diagnosis of COVID-19 by antigen detection in blood samples of the SARS-COV-2 nucleocapsid protein'. Together they form a unique fingerprint.

Cite this